Cases & Deals

PRP Diagnostic Imaging and PRP Group Investments sold to Crescent Capital Partners

Clients PRP Diagnostic Imaging (PRP) and PRP Group Investments (PRPG)

Jones Day advised PRP Diagnostic Imaging (PRP) and PRP Group Investments (PRPG) on the sale of PRP to private equity fund Crescent Capital Partners (Crescent). Crescent signed the deal to acquire 100% of PRP on June 9, 2020, valuing the company at AUD $440 million.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.